BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Pharm Country

  Aqua Pharmaceuticals Announces Launch Of Cordran® Ointment (Flurandrenolide Ointment, USP) 0.05%

  June 30, 2014

   · 

  1 min read
• Pharm Country

  NPS Pharmaceuticals, Inc. Release: FDA Approves Updated Labeling For Gattex® (Teduglutide [RDNA Origin]) For Injection To Include Long-Term Data

  June 30, 2014

   · 

  1 min read
• Business

  FSC LaboratoriesTo Market Aciphex® Sprinkle™ (Rabeprazole Sodium) In The U.S.

  June 30, 2014

   · 

  1 min read
• BioCapital

  K2M Added To The Russell 3000 Index

  June 30, 2014

   · 

  1 min read
• Pharm Country

  Advaxis, Inc.'s Cancer Immunotherapy Featured On CBS News

  June 30, 2014

   · 

  1 min read
• Policy

  Rockwell Medical Announces FDA Approves $2.2 Million Application Fee Refund For Triferic™ NDA

  June 30, 2014

   · 

  1 min read
• Drug Development

  Nora Therapeutics Presents Phase 1 Data On NT100 At The European Society Of Human Reproduction And Embryology Annual Meeting

  June 30, 2014

   · 

  1 min read
• Drug Development

  Amicus Therapeutics, Inc. Provides Updates And Final Analysis Plan For Phase 3 Fabry Monotherapy Study 012

  June 30, 2014

   · 

  1 min read
• Deals

  RedHill Biopharma Ltd. Acquires Phase 2 Oncology Drug MESUPRON® From Wilex AG

  June 30, 2014

   · 

  1 min read
• Drug Development

  Veloxis Pharmaceuticals A/S Release: Envarsus® XR Demonstrates Lower Treatment Failure Rate In African-Americans Compared To Twice-Daily Tacrolimus (Prograf®)

  June 30, 2014

   · 

  1 min read